Skip to Main Content

Paper Details

IgM autoantibodies recognizing ACE2 are associated with severe COVID-19.
medRxiv
33
2020
ACE2, COVID-, COVID-19, IgG, IgM, IgM autoantibodies, SARS-, SARS-CoV-2, T-independent, angiotensin converting enzyme-2, anti-ACE2, endothelial cell, patients
Author NameAffiliation
Lauren M SauerJohns Hopkins Hospital
Lauren M SauerJohns Hopkins Hospital
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Oliver LaeyendeckerJohns Hopkins University School of Medicine
Brian T GaribaldiJohns Hopkins Biocontainment Unit, Johns Hopkins University School of Medicine
Richard E RothmanJohns Hopkins Hospital
Andrew PekoszBloomberg School of Public Health, Johns Hopkins University
Andrew PekoszBloomberg School of Public Health, Johns Hopkins University
Scott L ZegerBloomberg School of Public Health
Antony RosenJohns Hopkins University School of Medicine
Antony RosenJohns Hopkins University School of Medicine
  • 1 - 11

Datasets

Release 1.2